London [England]:The researchers have identified immune cell types that could be targeted to create particular immunotherapies for chemotherapy-resistant breast tumours.
Researchers from King's College London and The Institute of Cancer Research, London, with support from Breast Cancer Now, have performed a deep dive into the different immune markers within tumour tissues and blood samples of early breast cancer patients whose cancer failed to respond to chemotherapy given to them prior to surgery.
Read also: Excess weight is linked to a higher risk of COVID-19 infection
